Lung Transplant Questions: Use Specialist Advice and Current Information
Lung transplantation is a specialist treatment considered for selected people with severe lung disease. India’s National Organ and Tissue Transplant Organization includes a lung-transplant chapter in its transplant manual.
Eligibility, timing and alternatives require an assessment by the treating and transplant teams. A website about home air quality should not use transplant costs or waitlists to persuade someone to buy an air purifier.
Ask the transplant centre directly
| Topic | Questions to discuss |
|---|---|
| Suitability | Why is evaluation being considered, and what alternatives remain? |
| Waiting | What is the centre’s current process and how is urgency assessed? |
| Costs | What is included in the written estimate, and what follow-up expenses are separate? |
| Outcomes | Which patient group and time period do the quoted results describe? |
| Support | What caregiver, travel and follow-up arrangements would be required? |
Costs, waiting periods and centre services can change. Ask for current written information rather than relying on an undated national price range or a generic survival percentage.
Understand the benefits and risks
Transplantation may offer benefits for a suitable patient but also involves significant risks and ongoing care. NHS Blood and Transplant’s patient information explains the need to weigh these with the clinical team. UK service arrangements or statistics should not be treated as Indian programme outcomes.
Do not infer suitability from one lung-function number in an article. The decision involves the full medical assessment and the patient’s circumstances and preferences.
Home air treatment is a separate question
An air-treatment product is not a replacement for transplantation, medicines, oxygen or rehabilitation. This website does not establish that an aqi0 installation prevents end-stage lung disease or reduces someone’s likelihood of needing a transplant.
For a person already receiving care, discuss environmental concerns with their clinician. Any equipment supplier should explain the product’s actual capabilities and maintenance needs without promising a medical outcome.
For general measurement information, see the PM2.5 guide. aqi0’s technical note describes installation and product conditions, not medical treatment.
FAQ
Will more lungs be available in the future?
Indian organ donation is growing but slowly. MOHAN Foundation’s work has roughly tripled donations over 15 years. Even with aggressive growth, supply will lag demand for the foreseeable future.
Can I go abroad for transplant?
Yes, for those who can afford it. Common destinations include the US, Germany, Singapore. Costs are 3–10× Indian costs. Some centres’ outcomes are slightly better; the differential is real but modest at top Indian centres.
Should my parent get on the waitlist?
Discuss with their pulmonologist. The waitlist evaluation itself is rigorous; many candidates are turned down for age, comorbidities, or psychosocial reasons. The decision balances quality-of-life expectations on either side.
What about lung volume reduction surgery (LVRS)?
For specific COPD patterns, LVRS removes the worst-affected portions of the lung, allowing the remaining lung to function better. Less invasive than transplant; suitable for fewer patients. Discussed with a pulmonologist who specialises in this.
Is stem cell therapy a real option?
Not yet. Multiple clinical trials are exploring stem cell approaches for lung disease but no proven therapy exists. Beware of unregulated stem cell clinics in India making exaggerated claims.